134 related articles for article (PubMed ID: 30649065)
1. The influence of constraints on the efficient allocation of resources for HIV prevention.
Stopard IJ; McGillen JB; Hauck K; Hallett TB
AIDS; 2019 Jun; 33(7):1241-1246. PubMed ID: 30649065
[TBL] [Abstract][Full Text] [Related]
2. Evaluating the potential impact and cost-effectiveness of dapivirine vaginal ring pre-exposure prophylaxis for HIV prevention.
Reidy M; Gardiner E; Pretorius C; Glaubius R; Torjesen K; Kripke K
PLoS One; 2019; 14(6):e0218710. PubMed ID: 31242240
[TBL] [Abstract][Full Text] [Related]
3. How should HIV resources be allocated? Lessons learnt from applying Optima HIV in 23 countries.
Stuart RM; Grobicki L; Haghparast-Bidgoli H; Panovska-Griffiths J; Skordis J; Keiser O; Estill J; Baranczuk Z; Kelly SL; Reporter I; Kedziora DJ; Shattock AJ; Petravic J; Hussain SA; Grantham KL; Gray RT; Yap XF; Martin-Hughes R; Benedikt CJ; Fraser-Hurt N; Masaki E; Wilson DJ; Gorgens M; Mziray E; Cheikh N; Shubber Z; Kerr CC; Wilson DP
J Int AIDS Soc; 2018 Apr; 21(4):e25097. PubMed ID: 29652100
[TBL] [Abstract][Full Text] [Related]
4. In the interests of time: improving HIV allocative efficiency modelling via optimal time-varying allocations.
Shattock AJ; Kerr CC; Stuart RM; Masaki E; Fraser N; Benedikt C; Gorgens M; Wilson DP; Gray RT
J Int AIDS Soc; 2016; 19(1):20627. PubMed ID: 26928810
[TBL] [Abstract][Full Text] [Related]
5. HIV prevention where it is needed most: comparison of strategies for the geographical allocation of interventions.
Anderson SJ; Ghys PD; Ombam R; Hallett TB
J Int AIDS Soc; 2017 Dec; 20(4):. PubMed ID: 29220115
[TBL] [Abstract][Full Text] [Related]
6. Modelling impact and cost-effectiveness of oral pre-exposure prophylaxis in 13 low-resource countries.
Pretorius C; Schnure M; Dent J; Glaubius R; Mahiane G; Hamilton M; Reidy M; Matse S; Njeuhmeli E; Castor D; Kripke K
J Int AIDS Soc; 2020 Feb; 23(2):e25451. PubMed ID: 32112512
[TBL] [Abstract][Full Text] [Related]
7. The cost and impact of scaling up pre-exposure prophylaxis for HIV prevention: a systematic review of cost-effectiveness modelling studies.
Gomez GB; Borquez A; Case KK; Wheelock A; Vassall A; Hankins C
PLoS Med; 2013; 10(3):e1001401. PubMed ID: 23554579
[TBL] [Abstract][Full Text] [Related]
8. Optimizing resource allocation for HIV/AIDS prevention programmes: an analytical framework.
Bautista-Arredondo S; Gadsden P; Harris JE; Bertozzi SM
AIDS; 2008 Jul; 22 Suppl 1():S67-74. PubMed ID: 18664956
[TBL] [Abstract][Full Text] [Related]
9. Cost-effectiveness of Injectable Preexposure Prophylaxis for HIV Prevention in South Africa.
Glaubius RL; Hood G; Penrose KJ; Parikh UM; Mellors JW; Bendavid E; Abbas UL
Clin Infect Dis; 2016 Aug; 63(4):539-47. PubMed ID: 27193745
[TBL] [Abstract][Full Text] [Related]
10. Optimal allocation of HIV resources among geographical regions.
Kedziora DJ; Stuart RM; Pearson J; Latypov A; Dierst-Davies R; Duda M; Avaliani N; Wilson DP; Kerr CC
BMC Public Health; 2019 Nov; 19(1):1509. PubMed ID: 31718603
[TBL] [Abstract][Full Text] [Related]
11. Dapivirine vaginal ring for HIV prevention: modelling health outcomes, drug resistance and cost-effectiveness.
Glaubius R; Ding Y; Penrose KJ; Hood G; Engquist E; Mellors JW; Parikh UM; Abbas UL
J Int AIDS Soc; 2019 May; 22(5):e25282. PubMed ID: 31074936
[TBL] [Abstract][Full Text] [Related]
12. Cost and cost-effectiveness analysis of pre-exposure prophylaxis among men who have sex with men in two hospitals in Thailand.
Suraratdecha C; Stuart RM; Manopaiboon C; Green D; Lertpiriyasuwat C; Wilson DP; Pavaputanon P; Visavakum P; Monkongdee P; Khawcharoenporn T; Tharee P; Kittinunvorakoon C; Martin M
J Int AIDS Soc; 2018 Jul; 21 Suppl 5(Suppl Suppl 5):e25129. PubMed ID: 30033559
[TBL] [Abstract][Full Text] [Related]
13. The impact of self-selection based on HIV risk on the cost-effectiveness of preexposure prophylaxis in South Africa.
Jamieson L; Gomez GB; Rebe K; Brown B; Subedar H; Jenkins S; Shoko N; Bekker LG; Johnson LF; Meyer-Rath G
AIDS; 2020 May; 34(6):883-891. PubMed ID: 32004205
[TBL] [Abstract][Full Text] [Related]
14. The global Optima HIV allocative efficiency model: targeting resources in efforts to end AIDS.
Kelly SL; Martin-Hughes R; Stuart RM; Yap XF; Kedziora DJ; Grantham KL; Hussain SA; Reporter I; Shattock AJ; Grobicki L; Haghparast-Bidgoli H; Skordis-Worrall J; Baranczuk Z; Keiser O; Estill J; Petravic J; Gray RT; Benedikt CJ; Fraser N; Gorgens M; Wilson D; Kerr CC; Wilson DP
Lancet HIV; 2018 Apr; 5(4):e190-e198. PubMed ID: 29540265
[TBL] [Abstract][Full Text] [Related]
15. Cost-effectiveness and budget effect of pre-exposure prophylaxis for HIV-1 prevention in Germany from 2018 to 2058.
van de Vijver DAMC; Richter AK; Boucher CAB; Gunsenheimer-Bartmeyer B; Kollan C; Nichols BE; Spinner CD; Wasem J; Schewe K; Neumann A
Euro Surveill; 2019 Feb; 24(7):. PubMed ID: 30782266
[TBL] [Abstract][Full Text] [Related]
16. Estimating the range of potential epidemiological impact of pre-exposure prophylaxis: run-away success or run-away failure?
Cremin Í; Hallett TB
AIDS; 2015 Mar; 29(6):733-8. PubMed ID: 25849836
[TBL] [Abstract][Full Text] [Related]
17. The impact and cost-effectiveness of combined HIV prevention scenarios among transgender women sex-workers in Lima, Peru: a mathematical modelling study.
Bórquez A; Guanira JV; Revill P; Caballero P; Silva-Santisteban A; Kelly S; Salazar X; Bracamonte P; Minaya P; Hallett TB; Cáceres CF
Lancet Public Health; 2019 Mar; 4(3):e127-e136. PubMed ID: 30683587
[TBL] [Abstract][Full Text] [Related]
18. What do we know about the cost-effectiveness of HIV preexposure prophylaxis, and is it affordable?
Cambiano V; Miners A; Phillips A
Curr Opin HIV AIDS; 2016 Jan; 11(1):56-66. PubMed ID: 26569182
[TBL] [Abstract][Full Text] [Related]
19. Cost-Effectiveness of HIV Pre-exposure Prophylaxis Among Heterosexual Men in South Africa: A Cost-Utility Modeling Analysis.
Vogelzang M; Terris-Prestholt F; Vickerman P; Delany-Moretlwe S; Travill D; Quaife M
J Acquir Immune Defic Syndr; 2020 Jun; 84(2):173-181. PubMed ID: 32141959
[TBL] [Abstract][Full Text] [Related]
20. Optimal allocation of resources in female sex worker targeted HIV prevention interventions: model insights from Avahan in South India.
Panovska-Griffiths J; Vassall A; Prudden HJ; Lépine A; Boily MC; Chandrashekar S; Mitchell KM; Beattie TS; Alary M; Martin NK; Vickerman P
PLoS One; 2014; 9(10):e107066. PubMed ID: 25271808
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
